FDA Approves First Generic of HIV Prevention Drug, Lenacapavir
The US Food and Drug Administration (FDA) has approved the first generic version of lenacapavir, the highly effective twice-yearly injection to prevent HIV, developed by Dr Reddy’s Laboratories based in India. Dr Reddy’s was one of six pharmaceutical manufacturers that was granted a non-exclusive, royalty-free voluntary licensing agreement from Gilead, which developed lenacapavir. The agreement,…
We haven't written up this one. Health Policy Watch has the full story — the link below goes straight to it.
